Allogene Therapeutics CFO Geoffrey Parker to retire Nov. 6
ALLO•CFO retirement announced
Allogene Therapeutics CFO Geoffrey Parker will retire effective Nov. 6, 2026.
Parker will continue to lead the finance organization through his retirement date.
An external search is underway to identify his successor.




